Urology Today.net

Site updated at Monday, 30 March 2015

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



genetic changes1 - artificial1 - spina bifida3 - laparoscopic operations1 - obstructive lower urinary tract symptoms1 - egfr1 - pomegranate juice1 - laparoscopic partial nephrectomy1 - ckd progression1 - mortality1 - obese kidney transplant recipients1 - pelvic inflammatory disease2 - primary care1 - cryptorchidism1 - metastatic cancer1 - xtandi1 - bilateral nerve sparing1 - urology2 - quality of life1 - european association of urology1 - treatment of prostate cancer1 - robotic stereotactic radiosurgery1 - multiple myeloma1 - prostate cancer drug2 - kidney recipients1 - srs1 - kidney stone attack1 - larry greenbaum1 - urethral hypermobility4 - advanced stage1 -